Game-changing therapeutic nanoparticles for neuroscience, chronic degenerative diseases and orthopaedics.
Allegro Biotech has raised $6.0M in total funding. The most recent round was Seed. The last funding was announced in April 2023.
Allegro Biotech's investors include Meusinvest (Noshaq), KBC, Annie Vereecken.
Allegro Biotech is headquartered in Liîge, Belgium.
Game-changing therapeutic nanoparticles for neuroscience, chronic degenerative diseases and orthopaedics.
Allegro Biotech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allegro Biotech — Funding & Investors." VCBacked, April 25, 2023, https://www.vcbacked.co/company/allegro-biotech. Accessed October 31, 2026.
VCBacked. (2023). Allegro Biotech — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/allegro-biotech
{{cite web |title=Allegro Biotech — Funding & Investors |url=https://www.vcbacked.co/company/allegro-biotech |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated